New hope for kidney transplant patients: drug aims to prevent early organ failure
NCT ID NCT07020832
Summary
This study is testing whether an investigational drug called pegcetacoplan can help prevent a common complication called delayed graft function (DGF) after a kidney transplant. DGF means the new kidney doesn't work right away, often requiring temporary dialysis. The trial will enroll 320 adults at high risk for DGF to see if the drug helps the kidney start working faster and reduces the need for dialysis after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
RECRUITINGSão Paulo, 01323-001, Brazil
Conditions
Explore the condition pages connected to this study.